Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

NEELAPU, SATTVA S

One or more keywords matched the following items that are connected to NEELAPU, SATTVA S

Item Type	Name
Concept	Precursor Cell Lymphoblastic Leukemia-Lymphoma
Concept	Lymphoma, T-Cell
Concept	Burkitt Lymphoma
Concept	Lymphoma, Large B-Cell, Diffuse
Concept	Lymphoma, T-Cell, Peripheral
Concept	Lymphoma, Extranodal NK-T-Cell
Concept	Lymphoma, Non-Hodgkin
Concept	Lymphoma, B-Cell
Concept	Lymphoma, Mantle-Cell
Concept	Lymphoma, Follicular
Concept	Lymphoma
Concept	Lymphoma, Large-Cell, Anaplastic
Concept	Lymphoma, B-Cell, Marginal Zone
Academic Article	Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment.
Academic Article	TCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas.
Academic Article	Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial.
Academic Article	Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: an open label, single arm, phase II trial.
Academic Article	Phase III randomized trial of patient-specific vaccination for previously untreated patients with follicular lymphoma in first complete remission: protocol summary and interim report.
Academic Article	Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles.
Academic Article	Therapeutic lymphoma vaccines: importance of T-cell immunity.
Academic Article	BiovaxID: a personalized therapeutic cancer vaccine for non-Hodgkin's lymphoma.
Academic Article	Vaccine therapy for B-cell lymphomas: next-generation strategies.
Academic Article	Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.
Academic Article	Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials.
Academic Article	Identification of human idiotype-specific T cells in lymphoma and myeloma.
Academic Article	HDM-2 inhibition suppresses expression of ribonucleotide reductase subunit M2, and synergistically enhances gemcitabine-induced cytotoxicity in mantle cell lymphoma.
Academic Article	Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma.
Academic Article	Combination of Pim kinase inhibitor SGI-1776 and bendamustine in B-cell lymphoma.
Academic Article	The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma.
Academic Article	Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma.
Academic Article	A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy.
Academic Article	Therapeutic vaccine for lymphoma.
Academic Article	A novel proteoliposomal vaccine elicits potent antitumor immunity in mice.
Academic Article	Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma.
Academic Article	Survivin DNA vaccine generated specific antitumor effects in pancreatic carcinoma and lymphoma mouse models.
Academic Article	Placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphoma.
Academic Article	Idiotype vaccination as consolidation therapy: time for integration into standard of care for follicular lymphoma?
Academic Article	MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response.
Academic Article	Immune evasion of mantle cell lymphoma: expression of B7-H1 leads to inhibited T-cell response to and killing of tumor cells.
Academic Article	Phase I study of panobinostat plus everolimus in patients with relapsed or refractory lymphoma.
Academic Article	Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma.
Academic Article	90Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease.
Academic Article	Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Academic Article	Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigen.
Academic Article	A novel proteoliposomal vaccine induces antitumor immunity against follicular lymphoma.
Academic Article	Vaccination strategies in follicular lymphoma.
Academic Article	Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma.
Academic Article	Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial.
Academic Article	Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma.
Academic Article	Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results.
Academic Article	Phase I multidose-escalation study of the anti-CD19 maytansinoid immunoconjugate SAR3419 administered by intravenous infusion every 3 weeks to patients with relapsed/refractory B-cell lymphoma.
Academic Article	Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial.
Academic Article	Nuclear translocation of B-cell-specific transcription factor, BACH2, modulates ROS mediated cytotoxic responses in mantle cell lymphoma.
Academic Article	Induction of p53-mediated transcription and apoptosis by exportin-1 (XPO1) inhibition in mantle cell lymphoma.
Academic Article	Double hit lymphoma: the MD Anderson Cancer Center clinical experience.
Academic Article	A novel strategy for rapid and efficient isolation of human tumor-specific CD4(+) and CD8(+) T-cell clones.
Academic Article	Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma.
Academic Article	Vaccine site inflammation potentiates idiotype DNA vaccine-induced therapeutic T cell-, and not B cell-, dependent antilymphoma immunity.
Academic Article	Phase II study of yttrium-90-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphoma.
Academic Article	Expression of histone deacetylases in lymphoma: implication for the development of selective inhibitors.
Academic Article	Prospective isolation of clonogenic mantle cell lymphoma-initiating cells.
Academic Article	Essential role of TAK1 in regulating mantle cell lymphoma survival.
Academic Article	Transcription and translation are primary targets of Pim kinase inhibitor SGI-1776 in mantle cell lymphoma.
Academic Article	Detection of circulating tumour DNA in patients with aggressive B-cell non-Hodgkin lymphoma.
Academic Article	Cloning of B cell lymphoma-associated antigens using modified phage-displayed expression cDNA library and immunized patient sera.
Academic Article	8-Aminoadenosine inhibits Akt/mTOR and Erk signaling in mantle cell lymphoma.
Academic Article	Phase I study of a novel oral Janus kinase 2 inhibitor, SB1518, in patients with relapsed lymphoma: evidence of clinical and biologic activity in multiple lymphoma subtypes.
Academic Article	Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen.
Academic Article	Hodgkin lymphoma untreated for six years presenting with tracheoesophageal fistula.
Academic Article	Therapy of newly diagnosed follicular lymphoma.
Academic Article	Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial.
Academic Article	Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial.
Academic Article	Mutations and microenvironment collude in FL.
Academic Article	Detection of classical Hodgkin lymphoma specific sequence in peripheral blood using a next-generation sequencing approach.
Academic Article	Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas.
Academic Article	Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography.
Academic Article	Novel immunologic approaches in lymphoma: unleashing the brakes on the immune system.
Academic Article	Lenalidomide, idelalisib, and rituximab are unacceptably toxic in patients with relapsed/refractory indolent lymphoma.
Academic Article	Targeting Wnt pathway in mantle cell lymphoma-initiating cells.
Academic Article	Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma.
Academic Article	Targeting the programmed death-1/programmed death-ligand 1 axis in lymphoma.
Academic Article	Characteristics and management of rash following lenalidomide and rituximab in patients with untreated indolent non-Hodgkin lymphoma.
Academic Article	Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphoma.
Academic Article	CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma.
Academic Article	Hedgehog inhibitors selectively target cell migration and adhesion of mantle cell lymphoma in bone marrow microenvironment.
Academic Article	Role of the tumor microenvironment in mature B-cell lymphoid malignancies.
Academic Article	Maternal and Fetal Outcomes After Therapy for Hodgkin or Non-Hodgkin Lymphoma Diagnosed During Pregnancy.
Academic Article	Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma
Academic Article	Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes
Academic Article	Hedgehog inhibitors selectively target cell migration and adhesion of mantle cell lymphoma in bone marrow microenvironment
Academic Article	Phase II clinical trail of patients with relapsed follicular lymphoma treated with a humanized antiprogrammed death-1 monoclonal antibody combined with rituximabrreport in the 54th ASH annual meeting
Academic Article	Non-hodgkin indolent B-Cell lymphoma
Academic Article	Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma
Academic Article	Gemcitabine, Fludarabine, and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
Academic Article	Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma
Academic Article	Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple myeloma
Academic Article	Molecular evidence of Zn chelation of the procaspase activating compound B-PAC-1 in B cell lymphoma
Academic Article	Premature closure of a phase II study of bendamustine, mitoxantrone and rituximab for patients with untreated high-risk follicular lymphoma due to severe haematological and infectious toxicity
Academic Article	Characteristics and management of rash following lenalidomide and rituximab in patients with untreated indolent non-Hodgkin lymphoma
Academic Article	Identification of human idiotype-specific T cells in lymphoma and myeloma
Academic Article	Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum Î²2-microglobulin level in patients with diffuse large b-cell lymphoma
Academic Article	The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma
Academic Article	Targeting Wnt pathway in mantle cell lymphoma-initiating cells
Academic Article	Anti-PD-1 antibodies for the treatment of B-cell lymphoma
Academic Article	Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD Anderson Cancer Center in the rituximab era
Academic Article	Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphoma
Academic Article	CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma
Academic Article	Anti-PD-1 antibodies for the treatment of B-cell lymphoma: Importance of PD-1+ T-cell subsets.
Academic Article	Premature closure of a phase II study of bendamustine, mitoxantrone and rituximab for patients with untreated high-risk follicular lymphoma due to severe haematological and infectious toxicity.
Academic Article	ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies.
Academic Article	Molecular evidence of Zn chelation of the procaspase activating compound B-PAC-1 in B cell lymphoma.
Academic Article	Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma.
Academic Article	Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum ?2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic model.
Academic Article	Idelalisib Impacts Cell Growth through Inhibiting Translation-Regulatory Mechanisms in Mantle Cell Lymphoma.
Academic Article	Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma.
Academic Article	Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple myeloma: an open-label, dose-escalation, phase 1 trial.
Academic Article	Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs.
Academic Article	The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.
Academic Article	3D microvascular model recapitulates the diffuse large B-cell lymphoma tumor microenvironment in vitro.
Academic Article	Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma.
Academic Article	Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.
Academic Article	Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma^.
Academic Article	High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study.
Academic Article	An interim analysis of the ZUMA-1 study of KTE-C19 in refractory, aggressive non-Hodgkin lymphoma.
Academic Article	Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphoma.
Academic Article	Absence of Grail promotes CD8+ T cell anti-tumour activity.
Academic Article	Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphoma.
Academic Article	Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisions.
Academic Article	Novel BAFF-Receptor Antibody to Natively Folded Recombinant Protein Eliminates Drug-Resistant Human B-cell Malignancies In Vivo.
Academic Article	Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study.
Academic Article	Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With R-CHOP.
Academic Article	The risk of central nervous system relapses in patients with peripheral T-cell lymphoma.
Academic Article	CAR T-Cell Therapy in Large B-Cell Lymphoma.
Academic Article	Radiation Therapy as an Effective Salvage Strategy for Secondary CNS Lymphoma.
Academic Article	Predictors of Hypothyroidism in Hodgkin Lymphoma Survivors After Intensity Modulated Versus 3-Dimensional Radiation Therapy.
Academic Article	Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.
Academic Article	Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.
Academic Article	Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol.
Academic Article	Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma.
Academic Article	Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy.
Academic Article	The promise of CAR T-cell therapy in aggressive B-cell lymphoma.
Academic Article	Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysis.
Academic Article	Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCL.
Academic Article	Stage I Non-Hodgkin Lymphoma: difference in survival outcome by primary extranodal site of involvement.
Academic Article	Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib.
Academic Article	Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial.
Academic Article	Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy.
Academic Article	Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy.
Academic Article	Stage I non-Hodgkin lymphoma: no plateau in disease-specific survival ?
Academic Article	Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma.
Academic Article	Long-term overall- and progression-free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non-Hodgkin lymphoma.
Academic Article	Frontline antibiotic therapy for early-stage Helicobacter pylori-negative gastric MALT lymphoma.
Academic Article	Chimeric Antigen Receptor-Engineered T Cell Therapy in Lymphoma.
Academic Article	Lenalidomide plus rituximab (R2 ) in previously untreated marginal zone lymphoma: subgroup analysis and long-term follow-up of an open-label phase 2 trial.
Academic Article	Early Stage Extranodal Follicular Lymphoma: Characteristics, Management, and Outcomes.
Academic Article	Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.
Academic Article	CAR-T efficacy: is conditioning the key?
Academic Article	CXCR5+CD8+ T cells are a distinct functional subset with an antitumor activity.
Academic Article	Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma.
Academic Article	Safety of CAR T-cell therapy in patients with B-cell lymphoma and chronic hepatitis B or C virus infection.
Academic Article	Managing the toxicities of CAR T-cell therapy.
Academic Article	Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in diffuse large B cell lymphoma.
Academic Article	Additional therapy improves outcomes in completely resected, limited-stage follicular lymphoma.
Academic Article	Radiation therapy for salivary gland MALT lymphoma: ultra-low dose treatment achieves encouraging early outcomes and spares salivary function.
Academic Article	Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
Academic Article	De novo CD5+ diffuse large B-cell lymphoma, NOS: clinical characteristics and outcomes in rituximab era.
Academic Article	Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphoma.
Academic Article	Development and Use of the Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy Axicabtagene Ciloleucel in Large B-Cell Lymphoma: A Review.
Academic Article	Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma.
Academic Article	Pretreatment SUVmax may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FL.
Academic Article	Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors.
Academic Article	Ataxia-telangiectasia mutated interacts with Parkin and induces mitophagy independent of kinase activity. Evidence from mantle cell lymphoma.
Academic Article	Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma.
Academic Article	The combination of ibrutinib and rituximab demonstrates activity in first-line follicular lymphoma.
Academic Article	Outcomes of older patients in ZUMA-1, a pivotal study of axicabtagene ciloleucel in refractory large B-cell lymphoma.
Academic Article	Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL.
Academic Article	Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients.
Academic Article	Imaging Surveillance of Limited-stage Classic Hodgkin Lymphoma Patients After PET-CT-documented First Remission.
Academic Article	Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.
Academic Article	Primary mediastinal large B-cell lymphoma in paediatric and adolescent patients: emerging questions in the era of immunotherapy.
Academic Article	Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma.
Academic Article	Impact of maintenance rituximab in patients with de novo transformed indolent B cell lymphoma.
Academic Article	Clinical efficacy of anakinra to mitigate CAR T-cell therapy-associated toxicity in large B-cell lymphoma.
Academic Article	Ibrutinib-based therapy for the treatment of marginal zone lymphoma with central nervous system involvement.
Academic Article	Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma.
Academic Article	Acute leucoencephalomyelopathy and quadriparesis after CAR T-cell therapy.
Academic Article	Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma.
Academic Article	Partial omission of bleomycin for early-stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes?
Academic Article	Initial report of a phase II study with R-FND followed by ibritumomab tiuxetan radioimmunotherapy and rituximab maintenance in patients with untreated high-risk follicular lymphoma.
Academic Article	Long-term follow-up of lenalidomide and rituximab as initial treatment of follicular lymphoma.
Academic Article	Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy.
Academic Article	Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas.
Academic Article	Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma.
Academic Article	Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma.
Academic Article	Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapy.
Academic Article	A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma.
Academic Article	Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma.
Academic Article	The impact of cell-of-origin, MYC/Bcl-2 dual expression and MYC rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy.
Academic Article	Safety of CAR T-cell therapy in kidney transplant recipients.
Academic Article	Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma.
Academic Article	Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma.
Academic Article	Radiation and CAR T-cell Therapy in Lymphoma: Future Frontiers and Potential Opportunities for Synergy.
Academic Article	Prognostic value of disease distribution in secondary central nervous system diffuse large B cell lymphoma treated with radiation therapy.
Academic Article	CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel.
Academic Article	CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicity.
Academic Article	Preclinical and phase I studies of KA2237, a selective and potent inhibitor of PI3K ?/d in relapsed refractory B cell lymphoma.
Academic Article	A prospective study on early PET/CT scans during the first cycle of salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma.
Academic Article	Comparison of 2-year outcomes with CAR T cells (ZUMA-1) vs salvage chemotherapy in refractory large B-cell lymphoma.
Academic Article	CD303 (BDCA-2) - a potential novel target for therapy in hematologic malignancies.
Academic Article	Cardiovascular events in patients treated with chimeric antigen receptor T-cell therapy for aggressive B-cell lymphoma.
Academic Article	Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial.
Academic Article	Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma.
Academic Article	Day 30 SUVmax predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapy.
Academic Article	A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapy.
Academic Article	Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial.
Academic Article	Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma.
Academic Article	Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma.
Academic Article	Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma.
Academic Article	Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression.
Academic Article	Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T Consortium.
Academic Article	Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses.
Academic Article	Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response.
Academic Article	Need for risk adjustment in comparative effectiveness and cost-effectiveness studies in r/r follicular lymphoma.
Academic Article	Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma.
Academic Article	Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma.
Academic Article	A polyamine-centric, blood-based metabolite panel predictive of poor response to CAR-T cell therapy in large B cell lymphoma.
Academic Article	Impact of conditioning chemotherapy on lymphocyte kinetics and outcomes in LBCL patients treated with CAR T-cell therapy.
Academic Article	Positron emission tomography derived metrics in relapsed or refractory large B-cell lymphoma with residual disease before autologous stem cell transplant.
Academic Article	A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL.
Academic Article	A 24-month updated analysis of the comparative effectiveness of ZUMA-5 (axi-cel) vs. SCHOLAR-5 external control in relapsed/refractory follicular lymphoma.
Academic Article	Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium.
Academic Article	Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large?B-cell lymphoma.
Academic Article	A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy.
Academic Article	PD-L1+ macrophages are associated with favorable features in primary mediastinal (thymic) large B-cell lymphoma.
Academic Article	A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma.
Academic Article	Prolonged cytopenia following CD19 CAR T?cell therapy is linked with bone marrow infiltration of clonally expanded IFN?-expressing CD8 T?cells.
Academic Article	A single-cell atlas of CD19 chimeric antigen receptor T?cells.
Academic Article	First-in-human clinical trial of personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma.
Academic Article	Real-world analysis of safety and efficacy of CAR T-cell therapy in lymphoma patients with decreased kidney function.
Academic Article	Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-Hodgkin lymphoma (ZUMA-5).
Academic Article	Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study.
Academic Article	Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T Consortium.
Academic Article	Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy.
Academic Article	Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas.
Academic Article	Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement.
Academic Article	A Comparison of 3-Year Follow-up of ZUMA-5 (Axicabtagene Ciloleucel) With SCHOLAR-5 in Relapsed/Refractory Follicular Lymphoma.
Academic Article	Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B-cell lymphoma after 2 or more lines of prior therapy.

Search Criteria

Lymphoma